Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
Br J Cancer ; 113(2): 321-6, 2015 Jul 14.
Article in English | MEDLINE | ID: mdl-26057450

ABSTRACT

BACKGROUND: Tongue squamous cell carcinoma (TSCC) is increasing in incidence, especially among young patients and preferably females. Infection with human papilloma virus (HPV) has been suggested as a cause of SCC in the head and neck, and the proportion of oropharyngeal cancers caused by HPV has steadily increased. METHODS: Samples from 109 patients with primary TSCC were analysed for the presence of HPV16 by in situ hybridisation and for expression of its surrogate marker p16 and the HPV receptor syndecan-1 by immunhistochemistry. RESULTS: No evidence of HPV16 DNA was observed in the tumours, although one-third showed p16 staining. There was no difference in the expression of the primary HPV receptor, syndecan-1, between TSCC and a group of tonsil SCC. CONCLUSION: Whereas p16 is expressed in some TSCCs, HPV16 is undetectable, therefore, p16 cannot be used as a surrogate marker for high-risk HPV-infection in this tumour. Despite presence of the HPV-receptor syndecan-1 in TSCC, HPV prefers the tonsillar environment. Lack of p16 associates with worse prognosis primarily in patients aged ⩽40 years with tongue SCC. The improved prognosis seen in p16-positive TSCC can be due to induction of a senescent phenotype or an inherent radiosensitivity due to the ability of p16 to inhibit homologous recombination repair.


Subject(s)
Carcinoma, Squamous Cell/virology , Head and Neck Neoplasms/virology , Human papillomavirus 16/isolation & purification , Neoplasm Proteins/physiology , Papillomavirus Infections/complications , Receptors, Virus/physiology , Syndecan-1/physiology , Tongue Neoplasms/virology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Cyclin-Dependent Kinase Inhibitor p16 , DNA, Viral/analysis , Female , Head and Neck Neoplasms/mortality , Humans , In Situ Hybridization , Male , Middle Aged , Neoplasm Proteins/analysis , Squamous Cell Carcinoma of Head and Neck , Syndecan-1/analysis , Tongue Neoplasms/mortality
2.
Pathol Res Pract ; 209(6): 393-6, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23642451

ABSTRACT

Extraskeletal osteosarcoma (ESOS) is a malignant mesenchymal tumor in which neoplastic cells produce bone osteoid in variable amounts. An 81-year-old woman presented with severe abdominal pain, tenesmus, constipation and rectal bleeding. The digital rectal exploration showed a large lesion of hard consistency, occupying the lumen, with the presence of splinters that "pierced" the endoscopist's glove. Endoscopic examination and CTscan revealed an ulcerative exophytic neoplasia of the lower rectum in which multiple calcified areas were found. The lesion showed no bone involvement. An abdominal perineal resection sec Miles was performed. The histological examination revealed a highly cellular mesenchymal lesion, with spindle and epithelioid cells with moderate nuclear pleomorphism. The calcified component consisted of widespread osteoid deposition. The immunohistochemical investigations of neoplastic cells showed strong positivity for vimentin and osteonectin. The definitive histological diagnosis of primary extraskeletal osteosarcoma arising from the colon-rectum was made. To our knowledge, only one previous case of colonic osteosarcoma was published in the literature in 2001, reported by Shimazu and other authors. The extreme rarity of the tumor at this location, also confirmed by morphological and immunohistochemical data, prompted us to present this case report and to review the literature.


Subject(s)
Colorectal Neoplasms/pathology , Ossification, Heterotopic/pathology , Osteosarcoma/pathology , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/analysis , Chemotherapy, Adjuvant , Colectomy , Colorectal Neoplasms/chemistry , Colorectal Neoplasms/therapy , Digital Rectal Examination , Fatal Outcome , Female , Humans , Immunohistochemistry , Osteosarcoma/chemistry , Osteosarcoma/therapy , Tomography, X-Ray Computed , Treatment Outcome
3.
Arq. bras. med. vet. zootec ; 62(2): 429-438, abr. 2010. ilus
Article in Portuguese | LILACS | ID: lil-551843

ABSTRACT

Estudaram-se os efeitos da adubação nitrogenada sobre o crescimento do capim Tifton 85 (Cynodon spp. cv. Tifton 85), em termos de ocorrência de plantas e altura do dossel, índice de área foliar e interceptação de radiação fotossinteticamente ativa. O estudo foi desenvolvido sobre um planossolo de ocorrência em campo experimental. Os tratamentos consistiram de níveis de N (0; 150; 300; 450 e 600kg/ha de N-ureia, aplicados em duas vezes), arranjados em um desenho experimental de blocos inteiramente ao acaso, com quatro repetições. As avaliações foram realizadas semanalmente, entre 10 e 40 dias após o corte. Tanto a ocorrência de plantas como a altura do dossel responderam à adubação nitrogenada, conforme um padrão de resposta que variou, sazonalmente, em função das doses de N em interação com as condições ambientais. A expansão da área foliar e a interceptação da radiação fotossinteticamente ativa associada, também foram controladas direta e proporcionalmente pelas doses de N aplicadas, sendo maximizadas a valores de índice de área foliar em torno de 4,0.


The effects of nitrogen (N) fertilization levels on the growth patterns of the grass Tifton 85 (Cynodon spp. cv.Tifton 85) were studied in terms of occurrence of plants, sward height, leaf area index, and photosynthetically active radiation interception (PARint). The field trial was made in an experimental area. Treatments consisted of N levels (0; 150; 300; 450; and 600kg/ha N-urea, split in two applications) arranged in an experimental design of entirely randomized blocks with four repetitions. Plots were weekly sampled, from the day 10th to 40th after cutting. Both occurrence of plants as well as sward height were responsive to nitrogen fertilization according to a response pattern that seasonally varied, depending on N rates and environmental conditions; thus, demonstrating their sensitivity as indicators of growth conditions and canopy structure. Leaf expansion and its associated PAR interception were also directly and proportionately controlled by N rates, being maximized to values of leaf area index around 4.0.


Subject(s)
Cynodon/growth & development , Soil Treatment/methods , Nitrogen/administration & dosage , Nitrogen/adverse effects
4.
J Exp Clin Cancer Res ; 26(2): 291-2, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17725112

ABSTRACT

In this manuscript for the first time we describe the concomitant diagnosis of primary renal non-Hodgkin lymphoma (PRL) and of a papillary urothelial cancer in a patient with megaloblastic anemia. PRL is a rare disease, since the kidney is one of the extranodal organs usually not containing lymphoid tissue. The disease usually affects adults with an average age of 60 years and slight male preponderance. Flank pain is the most common presenting symptom and different histologies have been reported. A review of literature indicated that simultaneous diagnosis of PRL and papillary urothelial carcinoma of the urether, makes our case unique. The early diagnosis of both diseases allowed the eradication of the two neoplasms by nephro-ureterecthomy and by performing subsequent systemic chemotherapy.


Subject(s)
Carcinoma, Papillary/diagnostic imaging , Kidney Neoplasms/diagnostic imaging , Lymphoma, Non-Hodgkin/diagnostic imaging , Ureteral Neoplasms/diagnostic imaging , Carcinoma, Papillary/complications , Carcinoma, Papillary/pathology , Early Diagnosis , Female , Humans , Kidney Neoplasms/complications , Kidney Neoplasms/pathology , Lymphoma, Non-Hodgkin/complications , Lymphoma, Non-Hodgkin/pathology , Tomography, X-Ray Computed , Ureteral Neoplasms/complications , Ureteral Neoplasms/pathology
5.
Oncogene ; 26(3): 382-94, 2007 Jan 18.
Article in English | MEDLINE | ID: mdl-16878156

ABSTRACT

We show that human osteosarcoma cells (Saos-2) have downregulation of alpha3beta1-integrin compared to normal bone cells; this was further described in human osteosarcomas and in a primary murine sarcoma. The alpha3 gene was silenced in Saos-2 cells causing a low expression of alpha3beta1-integrin and reduction in collagen attachment with increasing migratory capacity. Chromatin immunoprecipitation assay performed on alpha3 promoter established that Myc and Yin Yang protein (YY1) cooperate in tandem to downregulate the alpha3 gene. This silencing mechanism involves the binding of Myc and YY1 to DNA and formation of complexes among Myc/Max, YY1, CREB-binding protein and deacetylation activity. The promoter containing deletions of E-boxes or YY1 cassettes failed to downregulate the transcription of a reporter gene as well as the inhibition of deacetylation activity. Overexpression of both Myc and YY1 was necessary to determine the alpha3-integrin promoter downregulation in normal osteoblasts. This downregulation of alpha3beta1-integrin can contribute to the acquisition of a more aggressive phenotype. YY1 regulated negatively the Myc activity through a direct interaction with the Myc/Max and deacetylase complexes. This represents a novel silencing mechanism with broad implications in the transcription machinery of tumours.


Subject(s)
Gene Silencing , Integrin alpha3/genetics , Integrin alpha3beta1/metabolism , Osteosarcoma/metabolism , Proto-Oncogene Proteins c-myc/metabolism , YY1 Transcription Factor/metabolism , Animals , Base Sequence , Basic-Leucine Zipper Transcription Factors/metabolism , Blotting, Western , Bone Neoplasms/metabolism , Bone Neoplasms/pathology , Chromatin Immunoprecipitation , Collagen/metabolism , Down-Regulation , Electrophoretic Mobility Shift Assay , Female , Fluorescent Antibody Technique , Humans , Laminin/metabolism , Mice , Mice, Nude , Molecular Sequence Data , Osteoblasts/cytology , Osteoblasts/metabolism , Osteosarcoma/genetics , Osteosarcoma/pathology , Promoter Regions, Genetic/genetics , RNA, Small Interfering/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Transcription, Genetic , Transfection , Tumor Cells, Cultured , YY1 Transcription Factor/antagonists & inhibitors , YY1 Transcription Factor/genetics
6.
Eur J Gynaecol Oncol ; 27(3): 307-9, 2006.
Article in English | MEDLINE | ID: mdl-16800268

ABSTRACT

INTRODUCTION: Abdominal scar recurrence of endometrial carcinoma after abdominal total hysterectomy is very rare. We report a case of a 65-year-old woman who had two recurrences in the abdominal incisional scar after total hysterectomy. CASE REPORT: A 65-year-old woman underwent total hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy because of well-differentiated endometrial adenocarcinoma (Stage IIB). Thus, the patient was treated by external beam radiotherapy. She developed two recurrences in the abdominal incisional scar two and three years after total hysterectomy, respectively. Surgery plus chemotherapy and surgery plus hormonal therapy were used for treatment of the first and second scar recurrence, respectively. CONCLUSIONS: It is a very intriguing and controversial biologic question how neoplastic cells can implant and grow in an abdominal scar without other concomitant metastases. We report a review of the literature and the possible mechanism of recurrences in laparotomy wounds.


Subject(s)
Abdominal Wall , Adenocarcinoma/surgery , Cicatrix , Endometrial Neoplasms/surgery , Laparotomy , Neoplasm Recurrence, Local , Neoplasm Seeding , Adenocarcinoma/pathology , Aged , Cicatrix/etiology , Cicatrix/pathology , Endometrial Neoplasms/pathology , Female , Humans , Hysterectomy
7.
Eur J Gynaecol Oncol ; 27(3): 313-6, 2006.
Article in English | MEDLINE | ID: mdl-16800270

ABSTRACT

The term female adnexal tumor of probable Wolffian origin "FATWO" designs this tumor wich arises by the rare persisting remnants of the mesonephric duct (Wolffian duct). About 40 cases have been reported in literature. Few cases of recurrence have been reported, FATWO usually shows no signs of hormonal activity. We report a case of the youngest patient affected by FATWO in October 2002. At laparotomy the left adnexa were deformed by a well-capsulated mass, totally removed and sent to the pathologist with a specimen of peritoneal fluid and of the omentum. The histological examination showed a prevalent tubular structure with focal retiform area, without intraluminal mucines. Immunohistochemical findings of the case reported are similar to those described by other authors, except for inhibin which has not been detected by us. The cytofluorimetry showed the low presence of aneuploid cells, with a very low prolifing component (< 1%).


Subject(s)
Adnexal Diseases/pathology , Genital Neoplasms, Female/pathology , Wolffian Ducts , Adnexal Diseases/metabolism , Adult , Broad Ligament , Female , Flow Cytometry , Genital Neoplasms, Female/metabolism , Humans , Immunohistochemistry
8.
Infez Med ; 13(4): 255-8, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16388281

ABSTRACT

Brucellosis is endemic in the Mediterranean area. In spite of the false negative results, the standard agglutination test remains the routine test for the diagnosis of brucellosis in southern Italy. We present a case of a patient with undulant fever and erythema nodosum-like skin lesions, with negative serum agglutination test, but isolated positivity of the ELISA test for anti-Brucella IgM. A diagnosis of brucellosis for this patient was supported by the anamnestic and clinical data, and by the response to therapy. This case and a review of the literature urge us to consider the ELISA test indispensable for the serological diagnosis of brucellosis.


Subject(s)
Brucellosis/diagnosis , Enzyme-Linked Immunosorbent Assay , Erythema Nodosum/diagnosis , Immunoglobulin M/analysis , Adult , Animals , Brucellosis/immunology , Cattle , Erythema Nodosum/immunology , Female , Humans , Immunoglobulin M/immunology , Predictive Value of Tests
9.
Anticancer Res ; 24(3b): 1897-900, 2004.
Article in English | MEDLINE | ID: mdl-15274372

ABSTRACT

Kaposi's sarcoma (KS) of the tongue is extremely rare in immunocompetent patients. We report a case of KS of the tongue associated with a median rhomboid glossitis. The main clinical, pathological and immunohistochemical features allowed the differential diagnosis.


Subject(s)
Glossitis/pathology , Sarcoma, Kaposi/pathology , Tongue Neoplasms/pathology , Aged , Diagnosis, Differential , Glossitis/complications , Glossitis/diagnosis , Humans , Immunohistochemistry , Male , Sarcoma, Kaposi/complications , Sarcoma, Kaposi/diagnosis , Tongue Neoplasms/complications , Tongue Neoplasms/diagnosis
10.
Minerva Gastroenterol Dietol ; 50(4): 339-43, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15788990

ABSTRACT

Ranitidine may cause liver injuries ranging from transient, subclinical serum transaminases increase every 100-1,000 treated patients to cholestatic hepatitis in less than 1/100,000. Other H2-receptor antagonists are more dangerous: 11 toxic hepatitis cases have been reported as adverse effect after 1 year of marketed ebrotidine. A 75-year-old male with ischemic cardiopathy history was started on an 8 days treatment of oral ranitidine due to pirosis, without any other changes of therapy; 48 h after drug withdrawal, light-coloured stools, dark urine and icteric scleras developed. On hospital admission, 10 days later, physical examination showed slight hepatomegaly and severe jaundice with skin excoriations followed by serum mixed bilirubin further increase and aminotransferases activities mild rise. Total bilirubin peaked at 381.33 mmol/l (5.1-17.1) and progressively returned to normal, after discharge home, in 3 months and now, 1 year later, there is no sign of liver disease. Ultrasonographic biliary anomalies and the most frequent causes of liver damage were excluded. Liver biopsy confirmed ranitidine as the most likely cause of liver toxicity since histological and ultramicroscopical study revealed a drug-induced picture. We report a rare case of intrahepatic cholestasis jaundice related to ranitidine, a widely used drug. Diagnosis would need an ethically unacceptable rechallange test.


Subject(s)
Cholestasis, Intrahepatic/chemically induced , Histamine H2 Antagonists/adverse effects , Jaundice, Obstructive/chemically induced , Ranitidine/adverse effects , Aged , Cholestasis, Intrahepatic/pathology , Humans , Jaundice, Obstructive/pathology , Male
11.
Anticancer Res ; 23(5b): 4101-3, 2003.
Article in English | MEDLINE | ID: mdl-14666608

ABSTRACT

Canalicular adenoma is an uncommon benign neoplasm that occurs almost exclusively in the upper lip and, very rarely, in other sites. We describe a case arising in the left parotid gland as a firm, painful mass, in order to underline morphological and immunohistochemical findings, particularly in relation to differential diagnosis with low-grade carcinomas of the salivary glands.


Subject(s)
Adenoma/pathology , Parotid Neoplasms/pathology , Female , Humans , Immunohistochemistry , Middle Aged
12.
Anticancer Res ; 23(5b): 4105-8, 2003.
Article in English | MEDLINE | ID: mdl-14666609

ABSTRACT

Two cases of Merkel cell carcinoma (MCC) of the head and neck region are reported in order to stress their diversity in morphological, immunohistochemical and clinical findings. The remarkable variability of MCC has been analyzed, particularly in relation to the differential diagnosis and prognostic implications.


Subject(s)
Carcinoma, Merkel Cell/pathology , Head and Neck Neoplasms/pathology , Aged , Carcinoma, Merkel Cell/diagnosis , Carcinoma, Merkel Cell/metabolism , Diagnosis, Differential , Female , Head and Neck Neoplasms/diagnosis , Head and Neck Neoplasms/metabolism , Humans , Immunohistochemistry , Male
13.
Thyroid ; 12(9): 815-21, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12481948

ABSTRACT

We present a prospective study on the long-term efficacy of percutaneous ethanol injection (PEI) treatment of a large series of symptomatic thyroid cystic nodules (STCN). Ninety-eight patients (72 females and 26 males) were treated. The mean basal volume of the STCN was 35.3 mL. In 92 of 98 patients PEI treatment induced a greater than 50% nodule shrinkage, only 6 of 92 responder patients relapsed at a follow-up of 9 years. Moreover, all the patients had a significant clinical benefit because a significant reduction of the cyst-associated symptoms was recorded. Furthermore, a limited number of sessions was required for the treatment of cysts larger than 40 mL (mean +/- standard deviation [SD]: 2.7 +/- 0.75) demonstrating the feasibility of the procedure also in the treatment of large cysts. In conclusion, PEI is an effective and inexpensive procedure with a high patient compliance and long-lasting effects in the treatment of cysts larger than 40 mL.


Subject(s)
Ethanol/administration & dosage , Solvents/administration & dosage , Thyroid Nodule/drug therapy , Administration, Cutaneous , Adolescent , Adult , Aged , Cysts/diagnostic imaging , Cysts/drug therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Thyroid Nodule/diagnostic imaging , Treatment Outcome , Ultrasonography
15.
Minerva Stomatol ; 51(6): 279-83, 2002 Jun.
Article in Italian | MEDLINE | ID: mdl-12147981

ABSTRACT

A clinical case of neuroma resulting from an amputation which occurred following parotid surgery is reported. The present paper discusses the importance of differential diagnosis relating to this pathology and the surgical techniques that may contribute to setting a limit on its onset. Traumatic neuroma is a possible complication of parotid surgery together with motor deficiencies and Frey's syndrome and the less frequent salivary fistulas. It may also occur following oncological or plastic-reconstructive surgery. During parotidectomy operations, section of the great auricular nerve may be required to facilitate access to the parotid region. This manoeuvre may, however, also be associated with the onset of a neuroma during a time period varying from 2 to 10 years, according to the various authors who have examined the subject. The laterocervical tumefaction associated with neuroma poses a number of diagnostic problems as it has to be differentiated from a likely relapse or possibly from more complex inflammatory or metastatic lymphnodal pathology. A correct clinical and diagnostic multidisciplinary approach is fundamental if the pathology is to be classified in the right way and contributes to alleviating a state of mental unease in the patient that is associated with the sudden appearance of the tumefaction. Sectioning the nervous trunk by means of thermocautery and its subsequent sinking below the main trunk of the sternocleidomastoid muscle, are simple surgical manoeuvres that are useful for preventing the onset of traumatic neuroma.


Subject(s)
Amputation Stumps/pathology , Cervical Plexus/injuries , Neuroma/etiology , Parotid Gland/surgery , Peripheral Nervous System Neoplasms/etiology , Postoperative Complications/etiology , Electrocoagulation , Humans , Intraoperative Complications , Male , Neuroma/surgery , Parotid Gland/innervation , Peripheral Nervous System Neoplasms/surgery
16.
Thorax ; 57(4): 353-6, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11923556

ABSTRACT

BACKGROUND: Mesothelioma is the most commonly occurring primary pleural neoplasm. Several studies have documented an increase in the incidence of this malignancy during the last decades. Although the association between asbestos exposure and development of mesothelioma is generally accepted, the exact mechanism of carcinogenesis is unknown. Recently, Simian virus 40 large T antigen (SV40 Tag) expression has been detected in pleural mesothelioma. The ability of SV40 oncoproteins to inactivate p53 and retinoblastoma tumour suppressor proteins has been proposed as an important step in the pathogenesis of human mesothelioma. METHODS: To obtain a better understanding of the molecular mechanisms of the pathogenesis of mesothelioma, the expression of the cell cycle inhibitor p21(WAF1/CIP1) (p21), a downstream target of p53, was evaluated immunohistochemically in a group of 29 mesothelioma specimens already characterised for the presence of SV40 Tag sequences. RESULTS: Statistical analysis did not reveal any correlation between p21 expression and histopathological type of mesothelioma using the kappa(2) test (p=0.577). A significant positive relationship was found between p21 expression level and the patients' overall survival according to the Kaplan-Meier survival curves and using a log rank test (median difference in survival 7 months, 95% CI 4.8 to 9.9; p<0.001). CONCLUSIONS: Determination of p21 expression bears a prognostic significance in patients affected with mesothelioma, further underlining the role of SV40 in the pathogenesis of malignant pleural mesothelioma.


Subject(s)
Cyclins/metabolism , Mesothelioma/metabolism , Pleural Neoplasms/metabolism , Simian virus 40/immunology , Antigens, Viral/immunology , Cyclin-Dependent Kinase Inhibitor p21 , Humans , Immunohistochemistry/methods , Mesothelioma/mortality , Pleural Neoplasms/mortality , Survival Analysis , T-Lymphocytes/immunology
17.
J Cell Biochem ; 83(3): 364-72, 2001.
Article in English | MEDLINE | ID: mdl-11596105

ABSTRACT

The AP-2 transcription factor plays a pivotal role in regulating the expression of several genes involved in tumor growth and progression of melanoma. We determined, by Western blot, variation in the level of expression of AP-2 and three of its downstream targets, c-kit, E-cadherin, and p21 in several human melanoma cell lines and, by immunohistochemistry, in a group of 99 histological samples including benign and malignant melanocytic lesions. A significant negative correlation between AP-2 expression level and tumor thickness was found. Moreover, AP-2 expression was positively associated with E-cadherin and c-kit expression. In contrast, there was a significant negative association between AP-2 and p21 expression levels. These findings suggest that p21 is independent of AP-2 transactivator function during the latest phases of melanoma progression. Finally, AP-2, c-kit, E-cadherin, and p21 expression levels did not show to be able to distinguish between dysplastic nevi and nevi without dysplasia. We conclude that changes in the expression of these proteins are involved in the later phases of melanoma progression, and may be responsible for the transition from local invasive melanoma to metastasis.


Subject(s)
Cadherins/biosynthesis , Cyclins/biosynthesis , DNA-Binding Proteins/biosynthesis , Melanoma/metabolism , Proto-Oncogene Proteins c-kit/biosynthesis , Skin Neoplasms/metabolism , Transcription Factors/biosynthesis , Blotting, Western , Cell Nucleus/metabolism , Cyclin-Dependent Kinase Inhibitor p21 , Female , Humans , Immunohistochemistry , Male , Nevus/metabolism , Transcription Factor AP-2 , Tumor Cells, Cultured
18.
Article in English | MEDLINE | ID: mdl-11244373

ABSTRACT

A rare case of chondroid chordoma of the lateral skull base with laterocervical extension is reported. Clinical, radiological and pathological features of the tumor are described. This unusual location of chondroid chordoma enabled total resection of the neoplastic tissue through a combined laterocervical and far lateral transjugular approach.


Subject(s)
Chordoma/diagnosis , Skull Base Neoplasms/diagnosis , Adult , Chordoma/diagnostic imaging , Chordoma/pathology , Female , Humans , Immunohistochemistry/methods , Magnetic Resonance Imaging , Skull Base Neoplasms/diagnostic imaging , Skull Base Neoplasms/pathology , Tomography, X-Ray Computed
19.
Anticancer Res ; 20(5A): 3301-5, 2000.
Article in English | MEDLINE | ID: mdl-11062757

ABSTRACT

The first cyclin dependent kinase inhibitor to be discovered was the p21 cdk interacting protein (a.k.a., WAF1, Cip1, CAP20, Sdi1, mda6). p21 expression may or may not be dependent on p53. This pathway also inhibits DNA replication by merit of p21's interaction with PCNA, but it has also been shown that this same inhibitory interaction with p21 does not affect PCNA DNA repair abilities. We assessed the immunohistochemical expression of p21 protein in 60 curative surgical resected non small cell lung cancers relating it to the expression of PCNA to clarify the contribution of the p21/PCNA pathway to the development of NSCLC. We did not find any relationship between PCNA and p21 expression. This last result may indicate that the mechanism by which PCNA controls the DNA repair is the most important activity of this protein during lung cancer progression and development, compared to its contribution to cell proliferation. In fact, this last event is strongly counteracted by p21 expression, which in this last case works as an inhibitor of PCNA expression. In conclusion this study highlighted the important role of the p21/PCNA pathway in lung carcinogenesis, pointing out the contribution of PCNA to the response to lung aggression and not only it's role as a proliferation index. Therefore, these results offer a background to further study to evaluate potential novel therapeutic approaches to lung cancer treatment.


Subject(s)
Carcinoma, Non-Small-Cell Lung/metabolism , Cyclins/biosynthesis , Enzyme Inhibitors , Lung Neoplasms/metabolism , Proliferating Cell Nuclear Antigen/biosynthesis , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cyclin-Dependent Kinase Inhibitor p21 , Humans , Lung Neoplasms/pathology
20.
In Vivo ; 14(4): 487-92, 2000.
Article in English | MEDLINE | ID: mdl-10945163

ABSTRACT

A case of rare primary adenocarcinoma of the bulbomembranous portion of the male urethra is presented. The histological and immunohistochemical characteristics of this tumor are identical to those of colon adenocarcinomas. The pathogenesis can be explained either by neoplastic degeneration of globet cells found in the urethral epithelium or by malignant degeneration of persistent glandular elements that are embryonal residues. The patient was successfully treated with transurethral prostatectomy and with a high dose of radiation therapy.


Subject(s)
Adenocarcinoma/pathology , Colonic Neoplasms/pathology , Urethral Neoplasms/pathology , Adenocarcinoma/radiotherapy , Adenocarcinoma/surgery , Combined Modality Therapy , Humans , Male , Middle Aged , Prostatectomy , Urethra/pathology , Urethral Neoplasms/radiotherapy , Urethral Neoplasms/surgery , Urothelium/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...